यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - orphenadrine hydrochloride - oral tablet - 50mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - orphenadrine hydrochloride - oral solution - 10mg/1ml

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

part viiid drug tariff special order - orphenadrine hydrochloride - oral tablet - 50mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

poly pharmaceuticals, inc. - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - norgesic forte 50 mg/770mg/60 mg tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic forte tablets do not directly relax tense skeletal muscles in man. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic forte tablets do not directly relax tense skeletal muscles in man. because of the mild anti-cholinergic effect of orphenadrine, norgesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy, or obstructions at the bladder neck. norgesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphengesic forte (orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphengesic forte tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphengesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphengesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous h

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - norgesic tm (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic tm tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, norgesic tm tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. norgesic tm tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

कनाडा - अंग्रेज़ी - Health Canada

sterimax inc - orphenadrine citrate - liquid - 30mg - orphenadrine citrate 30mg - miscellaneous skeletal muscle relaxants

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

stat rx usa llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo-skeletal conditions. the mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate does not directly relax tense skeletal muscles in man. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardiospasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

carilion materials management - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate extended-release tablets, usp are indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug. safety and effectiveness in pediatric patients have not been established. orphenadrine citrate has been chronically abused for its euphoric effects.[1] the mood elevating effects may occur at therapeutic doses of orphenadrine.[2]

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

a-s medication solutions - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate injection is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate does not directly relax tense skeletal muscles in man. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug. orphenadrine has been chronically abused for its euphoric effects. the mood elevating effects may occur at therapeutic doses of orphenadrine.